Variant report
Variant | nsv947344 |
---|---|
Chromosome Location | chr1:187469101-187475889 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:187460603..187462421-chr1:187469087..187470836,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150089214 | chr1:187469139-187469140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560059450 | chr1:187469164-187469165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532348620 | chr1:187469181-187469182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184710851 | chr1:187469219-187469220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2383651 | chr1:187469234-187469235 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs545132241 | chr1:187469248-187469249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537793719 | chr1:187469275-187469276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs75791445 | chr1:187469304-187469305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557455198 | chr1:187469314-187469315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189029519 | chr1:187469318-187469319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181450161 | chr1:187469328-187469329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531516142 | chr1:187469351-187469352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554324006 | chr1:187469370-187469371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149282868 | chr1:187469426-187469427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565893427 | chr1:187469427-187469428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575072707 | chr1:187469432-187469433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540026032 | chr1:187469535-187469536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186464128 | chr1:187469559-187469560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74135634 | chr1:187469570-187469571 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs4465161 | chr1:187469578-187469579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs4233129 | chr1:187469590-187469591 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs4506428 | chr1:187469604-187469605 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs71635429 | chr1:187469633-187469634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376617600 | chr1:187469634-187469635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs74135635 | chr1:187469665-187469666 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs532157834 | chr1:187469696-187469697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552342257 | chr1:187469763-187469764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541350107 | chr1:187469777-187469778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531615698 | chr1:187469828-187469829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs4007480 | chr1:187469836-187469837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548526214 | chr1:187469837-187469838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558712660 | chr1:187469844-187469845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs398103459 | chr1:187469845-187469846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs74639569 | chr1:187469846-187469847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191290569 | chr1:187469898-187469899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534195052 | chr1:187469916-187469917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146356902 | chr1:187469937-187469938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570919980 | chr1:187469939-187469940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs139722519 | chr1:187469992-187469993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556701062 | chr1:187470001-187470002 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs576586983 | chr1:187470015-187470016 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142970483 | chr1:187470019-187470020 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577100327 | chr1:187470029-187470030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs373962815 | chr1:187470082-187470083 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555653727 | chr1:187470108-187470109 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541300013 | chr1:187470114-187470115 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs561633637 | chr1:187470172-187470173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146144013 | chr1:187470175-187470176 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539841959 | chr1:187470221-187470222 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559935917 | chr1:187470224-187470225 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Schizophrenia | 19197363 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17899364 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:187469000-187469800 | Enhancers | Fetal Heart | heart |
2 | chr1:187469800-187473800 | Weak transcription | Fetal Heart | heart |
3 | chr1:187470000-187471400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr1:187471400-187471800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr1:187473800-187474400 | Enhancers | Fetal Heart | heart |
6 | chr1:187473800-187474400 | Enhancers | HUVEC | blood vessel |